indications for glp-1 agonists A glimpse of the future: new molecules and GLP1 ๐ก๐ Ten Top Tips for the
Description
2017;6:e181
Tirzepatide versus semaglutide for weight loss: a meta-analysis of randomized controlled trials
Activation of GLP-1R engages cAMP/PKA and PI3K/Akt pathways overlapping with insulin receptor signaling
LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling
A systematic review and meta-analysis of the available RCT data showed that retatrutide-treated participants achieved a mean body weight reduction of 10.66 kg and a BMI reduction of 4.53 kg/m, with significant proportions achieving weight loss thresholds of 5%, 10%, 15%, and 20% versus placebo
